Nureca IPO is a healthcare and wellness products distributor and is all set to make a debut in the stock market with an issue size of 100 Cr.
Nureca IPO –Overview
| Nureca IPO Issue Date | 15-17 Feb 2021 |
| Nureca IPO Opening Date | 15 Feb 2021 |
| Nureca IPO Face Value | INR 10 per share |
| Nureca IPO Price | INR 400 per share |
| Nureca IPO Lot Size | 35 Shares |
| Issue Size | 100 Cr |
| Offer for sale | 100 Cr |
| Issue Type | Book built Issue IPO |
| Listing At | BSE, NSE. |
| QIB Shares Offered | 3.10 times |
| NII (HNI) Shares | 31.59 times |
| Company Promoters | Saurabh Goyal is the promoter of the company. |
Nureca IPO Limited IPO-Tentative Dates
| Nureca IPO opening date | 15 Feb 2021 |
| Nureca IPO closing date | 17 Feb 2021 |
| Basis of Allotment | 23 Feb 2021 |
| Initiation of Refunds | 24 Feb 2021 |
| The credit of Shares to Demat | 24 Feb 2021 |
| Nureca IPO Listing Date | 25 Feb 2021 |
Nureca IPO – Industry Overview.
According to the World Health Organization (WHO), chronic diseases will account for almost three-quarters of all deaths worldwide by 2020 71% of deaths will be due to ischemic heart disease, and 70% of deaths due to diabetes. The stress on the formal healthcare system is high in India and neighboring countries, with low Health care expenditure on one hand, and an increasing burden of chronic diseases, on the other hand, which has led healthcare professionals to recommend a wide variety of technologies in nontechnology to help institutional settings to monitor and manage patients. These monitor patients with acute and chronic medical conditions, but also help with disease prevention and lifestyle choices.
Nureca IPO – Company Overview
Nureca Limited is a healthcare and wellness products distributor. The company aims to offer the best quality, durable, and innovative tools to customers to monitor chronic diseases and to improve their lifestyle.
The firm has a well-diversified product portfolio including Chronic Device Products, Orthopedic products, Mother and Child products, Nutrition Supplements, and Lifestyle products to meet the Indian healthcare market requirements. It is the first digital company to sell such products through its website drtust.in and other online partners i.e., e-commerce players, retailers, and distributors.
Nureca IPO -Objectives
- To meet the working capital requirements of the business.
- To meet general corporate purposes.
Nureca IPO – Financial Statements
| Particulars | 31-Dec-20 | 31-Mar-20 | 31-Mar-19 |
| Total Assets | 1,024.88 | 338.83 | 235.18 |
| Total Revenue | 1,229.73 | 994.87 | 619.83 |
| Profit After Tax | 361.80 | 63.95 | 62.26 |
Nureca IPO – Strengths
- Diversified product portfolio.
- Experienced promoter and management team.
- Strong online distribution network.
- Premium quality healthcare and wellness products.
Company Contact Information
Nureca Limited
128 Gala Number Udyog Bhavan
1st Floor Sonawala Lane,
Goregaon (East), Mumbai
Phone: +91-22-49616173
Email: cs@nureca.com
Website: http://www.nureca.com/
Nureca limited IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: nureca.ipo@linkintime.co.in
Website: https://linkintime.co.in/
